Trial Outcomes & Findings for Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer (NCT NCT03885908)
NCT ID: NCT03885908
Last Updated: 2024-03-25
Results Overview
percentage of recommendations that were followed by the surgery team
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
20 participants
Primary outcome timeframe
2 years
Results posted on
2024-03-25
Participant Flow
Participant milestones
| Measure |
In-person Geriatric Co-management Group
"In-person" geriatric consults to be done via telemedicine due to the current pandemic and consideration for patient safety.
|
Automated Geriatric Co-management Program Group
automated geriatric co-management: Following completion of the eRFA, the summary of impairments as well as the recommendations generated by the study team (hard-copy or email) will be provided in real-time to the surgery team for their attention.
|
|---|---|---|
|
Overall Study
STARTED
|
11
|
9
|
|
Overall Study
COMPLETED
|
8
|
7
|
|
Overall Study
NOT COMPLETED
|
3
|
2
|
Reasons for withdrawal
| Measure |
In-person Geriatric Co-management Group
"In-person" geriatric consults to be done via telemedicine due to the current pandemic and consideration for patient safety.
|
Automated Geriatric Co-management Program Group
automated geriatric co-management: Following completion of the eRFA, the summary of impairments as well as the recommendations generated by the study team (hard-copy or email) will be provided in real-time to the surgery team for their attention.
|
|---|---|---|
|
Overall Study
Patient deemed to be ineligible due to language preference
|
1
|
0
|
|
Overall Study
Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.
|
1
|
0
|
|
Overall Study
Patient did not undergo surgery within 2 months of consent.
|
1
|
1
|
|
Overall Study
Patient unable to complete appointment - withdrawn from study
|
0
|
1
|
Baseline Characteristics
Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer
Baseline characteristics by cohort
| Measure |
In-person Geriatric Co-management Group
n=11 Participants
"In-person" geriatric consults to be done via telemedicine due to the current pandemic and consideration for patient safety.
|
Automated Geriatric Co-management Program Group
n=9 Participants
automated geriatric co-management: Following completion of the eRFA, the summary of impairments as well as the recommendations generated by the study team (hard-copy or email) will be provided in real-time to the surgery team for their attention.
|
Total
n=20 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
75 years
n=5 Participants
|
76 years
n=7 Participants
|
76 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
9 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
3 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
8 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
17 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
10 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
16 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
11 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 2 yearsPopulation: N/A data were not collected
percentage of recommendations that were followed by the surgery team
Outcome measures
Outcome data not reported
Adverse Events
In-person Geriatric Co-management Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 3 deaths
Automated Geriatric Co-management Program Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Armin Shahrokni, MD, MPH
Memorial Sloan Kettering Cancer Center
Phone: 646-888-3651
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place